Barry D Quart
Director at Kiniksa Pharmaceuticals International, plc (KNSA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 29SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 13,09912,546 held (−51%) | $50.10 | $656K | +59.2% |
| Apr 8SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 6,90112,546 held (−35%) | $50.00 | $345K | +59.6% |
| Feb 12SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 11012,546 held (−1%) | $45.00 | $5K | +77.3% |
| Feb 12SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 2,69012,546 held (−18%) | $45.00 | $121K | +77.3% |
| Feb 4SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 83012,546 held (−6%) | $45.00 | $37K | +77.3% |
| Feb 4SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 12,52812,546 held (−50%) | $45.27 | $567K | +76.2% |
| Feb 4SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 2,60212,546 held (−17%) | $45.02 | $117K | +77.2% |
| Dec 17SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 20,12912,546 held (−62%) | $41.51 | $836K | +92.2% |
- Sell
Director Barry D Quart sold $656K of KNSA at $50.10 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Barry D Quart sold $345K of KNSA at $50.00 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Barry D Quart sold $5K of KNSA at $45.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Barry D Quart sold $121K of KNSA at $45.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Barry D Quart sold $37K of KNSA at $45.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Barry D Quart sold $567K of KNSA at $45.27 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.